跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FEDAC TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
FEDAC TABLET
Approved
THERAPEUTIC
FEDAC TABLET
PT ACTAVIS INDONESIA (INDONESIA REP OF)
🇸🇬 Health Sciences Authority
Approval Date
Jun 7, 1989
Approval ID
a827eaff9e07734c
Company
PT ACTAVIS INDONESIA (INDONESIA REP OF)
Type
Therapeutic
Approval Details
Approval Id
a827eaff9e07734c
Drug Name
FEDAC TABLET
Product Name
FEDAC TABLET
Approval Number
SIN03116P
Approval Date
1989-06-07
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
R01BA52
Atc Item Name
pseudoephedrine, combinations
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
PSEUDOEPHEDRINE HCl
60 mg
TRIPROLIDINE HCl
2.5 mg
PSEUDOEPHEDRINE HCL
60 MG
TRIPROLIDINE HCL
2.5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 7, 1989
Approval ID
a827eaff9e07734c
Type
Therapeutic
Back to HSA Approvals